Wednesday, 27 September 2023
Home
Issues
2017
May 2017 Vol 5, No 5
April 2017 Vol 5, No 4
March 2017 Vol 5, No 3
February 2017 Vol 5, No 2
January 2017 Vol 5, No 1
2016
December 2016 Vol 4, No 12
November 2016 Vol 4, No 11
October 2016 Vol 4, No 10
September 2016 Vol 4, No 9
August 2016 Vol 4, No 8
July 2016 Vol 4, No 7
June 2016 Vol 4, No 6
May 2016 Vol 4, No 5
April 2016 Vol 4, No 4
March 2016 Vol 4, No 3
February 2016 Vol 4, No 2
January 2016 Vol 4, No 1
2015
December 2015 Vol 3, No 12
November 2015 Vol 3, No 11
October 2015 Vol 3, No 10
September 2015 Vol 3, No 9
August 2015 Vol 3, No 8
July 2015 Vol 3, No 7
June 2015 Vol 3, No 6
May 2015 Vol 3, No 5
April 2015 Vol 3, No 4
March 2015 Vol 3, No 3
February 2015 Vol 3, No 2
January 2015 Vol 3, No 1
2014
2013
Media Library
Video Library
Clinical Pharmacy
Medication Synchronization
Retail Clinic
Retail Pharmacy
Retail Pharmacy Education
Retail Pharmacy Operations
Audiocast Library
CE
Resources
Supplements
In the News
Calendar
Newsfeed
Reprints
About Us
About Inside Patient Care
About Novellus HC
About The Lynx Group
Contact Us
Editorial Policies
Editorial Board
Join our Editorial Board
Advertising Policy
Advertising Contacts
Mission Statement
Press Releases
Connect With Us
Medical Writer
Authored Items
Praluent (Alirocumab) for Hypercholesterolemia: The First FDA-Approved PCSK9 Inhibitor
Lisa A. Raedler, PhD, RPh
February 2016, Vol 4, No 2
in
Inside Cardiovascular Health
ProAir RespiClick (Albuterol Sulfate): First Breath-Actuated Inhaler Approved for the Treatment or Prevention of Bronchospasm
Lisa A. Raedler, PhD, RPh
November 2015, Vol 3, No 11
in
Inside Drug Update
Keytruda (Pembrolizumab): First PD-1 Inhibitor Approved for Previously Treated Unresectable or Metastatic Melanoma
Lisa A. Raedler, PhD, RPh
June 2015, Vol 3, No 6
in
Inside Drug Update
Zydelig (Idelalisib): First-in-Class PI3 Kinase Inhibitor Approved by the FDA for the Treatment of 3 Hematologic Malignancies
Lisa A. Raedler, PhD, RPh
February 2015, Vol 3, No 2
in
Drug Update
Eliquis (Apixaban) Received New Indications for DVT Prophylaxis After Hip/Knee Replacement Surgery and Risk Reduction for Recurrent DVT and PE
Lisa A. Raedler, PhD, RPh
December 2014, Vol 2, No 6
in
Drug Update
Aveed (Testosterone Undecanoate): A Novel Dosing Schedule Approved for Testosterone Replacement in Men with Hypogonadism
Lisa A. Raedler, PhD, RPh
June/July 2014, Vol 2, No 3
in
Drug Update
Last modified: July 24, 2014
Home
Issues
2017
May 2017 Vol 5, No 5
April 2017 Vol 5, No 4
March 2017 Vol 5, No 3
February 2017 Vol 5, No 2
January 2017 Vol 5, No 1
2016
December 2016 Vol 4, No 12
November 2016 Vol 4, No 11
October 2016 Vol 4, No 10
September 2016 Vol 4, No 9
August 2016 Vol 4, No 8
July 2016 Vol 4, No 7
June 2016 Vol 4, No 6
May 2016 Vol 4, No 5
April 2016 Vol 4, No 4
March 2016 Vol 4, No 3
February 2016 Vol 4, No 2
January 2016 Vol 4, No 1
2015
December 2015 Vol 3, No 12
November 2015 Vol 3, No 11
October 2015 Vol 3, No 10
September 2015 Vol 3, No 9
August 2015 Vol 3, No 8
July 2015 Vol 3, No 7
June 2015 Vol 3, No 6
May 2015 Vol 3, No 5
April 2015 Vol 3, No 4
March 2015 Vol 3, No 3
February 2015 Vol 3, No 2
January 2015 Vol 3, No 1
2014
2013
Media Library
Video Library
Clinical Pharmacy
Medication Synchronization
Retail Clinic
Retail Pharmacy
Retail Pharmacy Education
Retail Pharmacy Operations
Audiocast Library
CE
Resources
Supplements
In the News
Calendar
Newsfeed
Reprints
About Us
About Inside Patient Care
About Novellus HC
About The Lynx Group
Contact Us
Editorial Policies
Editorial Board
Join our Editorial Board
Advertising Policy
Advertising Contacts
Mission Statement
Press Releases
Connect With Us
Search
